R.E.C.K. Syringe

Two R.E.C.K. Syringes With Epinephrine Made by QuVa Pharma
To place an order, 

R.E.C.K. Syringe

(Ropivacaine, Epinephrine, Clonidine, & Ketorolac in Sodium Chloride Solution), 50 mL Fill, 50 mL Syringe

The Answer to More Easily Support Your Orthopedic Surgery Department!

  • Patented formula containing Epinephrine
  • Pre-filled syringes save your pharmacy time and reduce waste, and make it easy for your O.R. team to simply decant and draw up into their preferred syringe and needle combination
  • 100 ml total dose1 is achieved with two 50 ml syringes, as each 50 ml contains: 123 mg Ropivacaine; 0.25 mg Epinephrine; 0.04 mg Clonidine; 15 mg Ketorolac
  • 90-day Beyond Use Dating and room temperature storage helps pharmacy improve efficiency and reduce wastage
  • Supplied by an FDA registered 503B outsourcing facility
  • Shipped directly to your hospital pharmacy and available in all 50 states
Product #
Product Description
Fill Volume
Beyond Use Date


R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride Solution, 50 ml fill, 50 ml Syringe

50 ml

90 Days

Room Temperature

What is R.E.C.K Injection?

R.E.C.K injection is a patented, non-opioid formula containing the following active ingredients:
  • 123 mg Ropivacaine
  • 0.25 mg Epinephrine
  • 0.04 mg Clonidine
  • 15 mg Ketorolac
These ingredients are combined in a solution of sodium chloride to provide a total volume of 50 ml per ready-to-administer syringe. The Beyond Use Date (BUD) for R.E.C.K. is 90 days, and it should be stored at room temperature.

How to use R.E.C.K

R.E.C.K solution is a sterile solution and comes in a pre-filled, ready-to-administer container to save time and reduce waste. OR team members can simply decant the product into a sterile container and draw it up into their preferred combination of syringe and needle. They can then administer R.E.C.K as a periarticular injection.

R.E.C.K & Knee Replacement Surgery

An injection of ropivacaine, epinephrine, clonidine and ketolorac (R.E.C.K) is used as part of a multimodal pain regimen as a way to minimize postoperative pain and support patients’ recovery from their surgery. Please see this The Journal of Arthroplasty prospective, randomized, double-blind study for appropriate use of R.E.C.K.

Multimodal Pain Management

Multimodal therapy is the preferred approach to postoperative pain control for knee replacement surgery, meaning practitioners use a combination of R.E.C.K and other medicines to minimize pain1https://www.drlikover.com/resources/learn-pain-reduction/. For example, patients can receive a combination of celecoxib, gabapentin and even Tylenol before surgery. They can also receive non-opioid R.E.C.K periarticular injection during the surgery so they can have postoperative pain control. Here are a few resources that discuss this approach:  Arthroplasty Today A state-of-the-art pain protocol for total knee replacement, David F. Dalury, MD.

Non-Opioid, Ready-to-Administer Sterile Solution for Periarticular Injection

Physician Using a QuVa Pharma R.E.C.K. Syringe With Epinephrine to Perform a Periarticular Injection

1Kelley, Todd C., et al. “Efficacy of Multimodal Perioperative Analgesia Protocol with Periarticular Medication Injection in Total Knee Arthroplasty: A Randomized, Double-Blinded Study.” The Journal of Arthroplasty, vol. 28, Sept. 2013, pp. 1274–1277.